Results 151 to 160 of about 150,811 (312)

Independent and synergistic effects of maternal and paternal obesogenic diets on offspring early‐life outcomes in the rat

Experimental Physiology, EarlyView.
Abstract Independent effects of maternal obesogenic diets on offspring outcomes are acknowledged, but data on paternal and combined maternal–paternal obesity remain limited. We investigated independent and combined maternal–paternal effects of an obesogenic (OB) high‐fat, high‐sugar diet on offspring outcomes.
Khurram Jahangir Toor, Mehwish Abbasi, Swetha Muralidharan, Elisa Weiss, Elwyn C. Firth, Anna P. Ponnampalam, David S. Musson, Mark H. Vickers, Benjamin B. Albert   +8 more
wiley   +1 more source

Recurrent hepatocellular carcinoma treated by laparoscopic non-anatomical liver resection via the retroperitoneal approach: a case report. [PDF]

Front Surg
Zhang K, Liu Y, Liu B, Ge R.
europepmc   +1 more source

Real‐world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study

International Journal of Cancer, Volume 159, Issue 3, Page 683-698, 1 August 2026.
What's New? Although patients with melanoma brain metastases (MBM) may benefit from treatment with immune checkpoint inhibitors (ICIs), which are known to improve survival in advanced melanoma, MBM patients have often been excluded from trials evaluating ICIs.
Ralf Gutzmer, Michael Weichenthal, Thomas Eigentler, Peter Mohr, Thomas Sickmann, Pia Dücker, Christoffer Gebhardt, Sebastian Haferkamp, Katharina C. Kähler, Friedegund Meier, Claudia Pföhler, Anca Sindrilaru, Patrick Terheyden, Imke von Wasielewski, Selma Ugurel, Jens Ulrich, Jochen Utikal, Carsten Weishaupt, Dirk Schadendorf   +18 more
wiley   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson, Ingrid Winship, Gary Hammerschlag, Laura Scardamaglia   +3 more
wiley   +1 more source

Retroperitoneal Malignant Triton Tumor in a 6-Year-Old Child Mimicking Wilms Tumor: A Case Report. [PDF]

Int Med Case Rep J
Ilumbulumbu MK, Nganza SK, Elomba DM, Posite CM, Sylvie VV, Bahati MM, Bahati FL, Ndanga E, Vahaviraki FM, Bomongo EK, Sokoni RM, Kirongozi L, Moreels R.   +12 more
europepmc   +1 more source

Post‐relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans‐Atlantic RPS Working Group

Cancer, 2017
A. MacNeill, R. Miceli, D. Strauss, S. Bonvalot, P. Hohenberger, F. van Coevorden, P. Rutkowski, D. Callegaro, A. Hayes, C. Honoré, M. Fairweather, A. Cannell, J. Jakob, R. Haas, Milena Szacht, M. Fiore, P. Casali, R. Pollock, C. Raut, A. Gronchi, C. Swallow   +20 more
semanticscholar   +1 more source

A subset of high‐grade sarcomas with myogenic differentiation are associated with recurrent FGFR fusions

The Journal of Pathology: Clinical Research, Volume 12, Issue 4, July 2026.
Abstract Recurrent fusions involving FGFR1‐4 genes have been previously described in rare subsets of mostly benign chondroid and mesenchymal neoplasms involving bone and soft tissue. However, a more comprehensive analysis of sarcomas associated with FGFR fusions, including their incidence and histotypes, has not been performed.
Maximus CF Yeung, Carla Saoud, Sarah Chiang, Meera Hameed, Cristina R Antonescu   +4 more
wiley   +1 more source

Robotic retroperitoneal lymph node dissection: a stepwise technical guide. [PDF]

J Robot Surg
Bacaglini W, Dugarte JP, Eskenazi F, Bianco IA, Calderon J, Guevara R, Carneiro A, Sibanto G, Sotelo RJ, Medina LG.   +9 more
europepmc   +1 more source

Novel BRAF fusion in Erdheim–Chester disease with pulmonary manifestations: Importance of RNA‐based testing and response to MEK inhibition

Histopathology, EarlyView.
Igor Odintsov, Henry D. Tazelaar, Jerry C. Lee, Lloyd E. Damon, Walter Patrick Devine, Kirk D. Jones   +5 more
wiley   +1 more source

Navigating the Post‐BCMA/GPRC5D Landscape: Efficacy of Selinexor, Bortezomib, and Dexamethasone After Sequential Immunotherapy Failure in Penta‐Refractory Multiple Myeloma—A Multicenter Analysis

American Journal of Hematology, Volume 101, Issue 7, Page 1433-1439, July 2026.
ABSTRACT Patients with relapsed/refractory multiple myeloma (RRMM) who are penta‐drug refractory, defined as resistant to two proteasome inhibitors, two immunomodulatory agents, and an anti‐CD38 monoclonal antibody, face a dismal prognosis, particularly after exposure to T‐cell–redirecting therapies.
Maximilian Al‐Bazaz, Winfried Alsdorf, Lisa Leypoldt, Piet Sonnemann, Christoph Schaefers, Jule Artzenroth, Marie Harzer, Abdulaziz Kamili, Leandra Bartke, Leon Cords, Jan Vorwerk, Theo Leitner, Markus Maulhardt, Kerstin Brinkert, Annamaria Brioli, Tim Richardson, Udo Holtick, Stefan M. Hillmann, Hans Salwender, Cyrus Khandanpour, Carsten Bokemeyer, Katja Weisel, Ricardo Kosch   +22 more
wiley   +1 more source